Candel Therapeutics, Inc. (CADL)
6.20
-2.19
(-26.10%)
USD |
NASDAQ |
Nov 13, 16:00
6.05
-0.15
(-2.42%)
After-Hours: 19:59
Candel Therapeutics Market Cap : 471.93M for Nov. 13, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 13, 2026 | 471.93M |
| November 12, 2026 | 638.63M |
| November 11, 2026 | 701.81M |
| November 10, 2026 | 711.71M |
| November 09, 2026 | 722.36M |
| November 06, 2026 | 666.04M |
| November 05, 2026 | 611.99M |
| November 04, 2026 | 688.87M |
| November 03, 2026 | 671.36M |
| November 02, 2026 | 618.08M |
| October 30, 2026 | 634.07M |
| October 29, 2026 | 658.42M |
| October 28, 2026 | 659.95M |
| October 27, 2026 | 627.98M |
| October 26, 2026 | 592.96M |
| October 23, 2026 | 611.23M |
| October 22, 2026 | 637.87M |
| October 21, 2026 | 637.11M |
| October 20, 2026 | 657.66M |
| October 19, 2026 | 624.93M |
| October 16, 2026 | 623.41M |
| October 15, 2026 | 678.21M |
| October 14, 2026 | 690.39M |
| October 13, 2026 | 705.62M |
| October 12, 2026 | 744.44M |
| Date | Value |
|---|---|
| October 09, 2026 | 756.62M |
| October 08, 2026 | 735.30M |
| October 07, 2026 | 747.48M |
| October 06, 2026 | 751.29M |
| October 05, 2026 | 778.69M |
| October 02, 2026 | 774.88M |
| October 01, 2026 | 773.36M |
| September 30, 2026 | 794.68M |
| September 29, 2026 | 828.17M |
| September 28, 2026 | 851.76M |
| September 25, 2026 | 838.82M |
| September 24, 2026 | 879.17M |
| September 23, 2026 | 859.38M |
| September 22, 2026 | 902.00M |
| September 21, 2026 | 853.29M |
| September 18, 2026 | 825.88M |
| September 17, 2026 | 863.18M |
| September 16, 2026 | 838.82M |
| September 15, 2026 | 846.44M |
| September 14, 2026 | 812.56M |
| September 11, 2026 | 802.67M |
| September 10, 2026 | 862.42M |
| September 09, 2026 | 926.36M |
| September 08, 2026 | 959.09M |
| September 04, 2026 | 972.79M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Oragenics, Inc. | 0.9069M |
| Arcturus Therapeutics Holdings, Inc. | 237.93M |
| ACADIA Pharmaceuticals, Inc. | 3.240B |
| Alnylam Pharmaceuticals, Inc. | 22.09B |
| Anika Therapeutics, Inc. | 179.48M |
Market Cap Related Metrics
| PEG Ratio | -0.0252 |
| Price to Book Value | 3.696 |
| Price | 6.20 |
| Earnings Yield | -23.98% |
| PEGY Ratio | -0.0252 |